Short answer
CONMED Corp (CNMD) filed an 8-K current report with the SEC on March 13, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). CFO role vacant: Andrew Moller named Interim Principal Financial Officer effective March 15, 2026, signaling unplanned departure of prior CFO.
CONMED Corp 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- CFO role vacant: Andrew Moller named Interim Principal Financial Officer effective March 15, 2026, signaling unplanned departure of prior CFO
- Moller is an internal promotion from VP Corporate Controller/Principal Accounting Officer, a role he held only since April 2025
- Prior experience: Global Controller & CFO Asia-Pacific at Smith & Nephew (2019–2024) and Director of Internal Audit at Stanley Black & Decker
- No compensation change tied to interim appointment: suggests temporary, transitional role pending permanent CFO search
- CFO instability at a medtech company mid-fiscal year warrants monitoring; permanent hire announcement will be a key catalyst
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CONMED Corp 8-K filings
Get the next CNMD 8-K as it lands
Follow CNMD for push alerts, or ask the research agent what this filing means.